$75.56
Price
$6.1B
Market Cap
8.8
P/E Ratio
-75.0
Forward P/E
$8.60
EPS (TTM)
—
Dividend Yield
$1.7B
Cash
$2.5B
Total Debt
80M
Shares Out
$35.95
$87.50
52-Week Range
Institutional Ownership of PTC THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for PTC THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for PTC THERAPEUTICS INC
6 Months Insider Sentiment
Buy $0
Sell $8.9M
0
Buys
52
Sells
-8.9M
Net
18
Grants
Largest
$2.7M
Pauwels
$2.4M
Pauwels
$916K
MD
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 12, 2026 | Eric Pauwels | CHIEF BUSINESS OFFICER | SELL | 1.0K | $78.70 | $81K |
| Jan 09, 2026 | Eric Pauwels | CHIEF BUSINESS OFFICER | SELL | 1.7K | $77.41 | $133K |
| Jan 09, 2026 | Mark Elliott Boulding | EXEC. VP AND CLO | SELL | 1.5K | $77.46 | $118K |
| Jan 09, 2026 | Mark Elliott Boulding | EXEC. VP AND CLO | SELL | 686 | $78.71 | $54K |
| Jan 09, 2026 | Mark Elliott Boulding | EXEC. VP AND CLO | SELL | 107 | $79.52 | $9K |
| Jan 08, 2026 | Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | SELL | 881 | $76.45 | $67K |
| Jan 08, 2026 | Matthew B. Klein | CHIEF EXECUTIVE OFFICER | SELL | 2.5K | $76.45 | $192K |
| Jan 08, 2026 | Mark Elliott Boulding | EXEC. VP AND CLO | SELL | 2.5K | $76.56 | $190K |
| Jan 08, 2026 | Mark Elliott Boulding | EXEC. VP AND CLO | SELL | 1.3K | $76.45 | $98K |
| Jan 08, 2026 | Christine Marie Utter | SVP, CHIEF ACCOUNTING OFFICER | SELL | 1.0K | $76.45 | $79K |
| Jan 08, 2026 | Eric Pauwels | CHIEF BUSINESS OFFICER | SELL | 1.5K | $76.45 | $111K |
| Jan 08, 2026 | Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | SELL | 59 | $76.45 | $5K |
| Jan 08, 2026 | Eric Pauwels | CHIEF BUSINESS OFFICER | SELL | 587 | $76.98 | $45K |
| Jan 08, 2026 | Mark Elliott Boulding | EXEC. VP AND CLO | SELL | 265 | $77.07 | $20K |
| Jan 08, 2026 | Eric Pauwels | CHIEF BUSINESS OFFICER | SELL | 2.6K | $76.42 | $196K |
| Jan 08, 2026 | Lee Scott Golden | EVP & CHIEF MEDICAL OFFICER | SELL | 866 | $76.45 | $66K |
| Jan 07, 2026 | Mark Elliott Boulding | EXEC. VP AND CLO | SELL | 1.6K | $77.11 | $126K |
| Jan 07, 2026 | Mark Elliott Boulding | EXEC. VP AND CLO | EXERCISE | 751 | $38.10 | $29K |
| Jan 07, 2026 | Mark Elliott Boulding | EXEC. VP AND CLO | EXERCISE | 2.6K | $38.10 | $100K |
| Jan 07, 2026 | Mark Elliott Boulding | EXEC. VP AND CLO | SELL | 11 | $78.98 | $869 |
| Jan 07, 2026 | Mark Elliott Boulding | EXEC. VP AND CLO | SELL | 38 | $78.60 | $3K |
| Jan 07, 2026 | Mark Elliott Boulding | EXEC. VP AND CLO | SELL | 269 | $77.92 | $21K |
| Jan 07, 2026 | Mark Elliott Boulding | EXEC. VP AND CLO | SELL | 471 | $77.10 | $36K |
| Jan 07, 2026 | Mark Elliott Boulding | EXEC. VP AND CLO | SELL | 949 | $77.91 | $74K |
| Jan 07, 2026 | Mark Elliott Boulding | EXEC. VP AND CLO | SELL | 1.5K | $77.48 | $116K |
| Jan 07, 2026 | Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | SELL | 1.0K | $77.48 | $79K |
| Jan 07, 2026 | Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | SELL | 52 | $77.48 | $4K |
| Jan 07, 2026 | Matthew B. Klein | CHIEF EXECUTIVE OFFICER | SELL | 3.0K | $77.48 | $234K |
| Jan 07, 2026 | Eric Pauwels | CHIEF BUSINESS OFFICER | SELL | 1.4K | $77.48 | $105K |
| Jan 07, 2026 | Christine Marie Utter | SVP, CHIEF ACCOUNTING OFFICER | SELL | 1.2K | $77.45 | $96K |
| Jan 07, 2026 | Lee Scott Golden | EVP & CHIEF MEDICAL OFFICER | SELL | 642 | $77.48 | $50K |
| Jan 06, 2026 | Matthew B. Klein | CHIEF EXECUTIVE OFFICER | SELL | 5.1K | $76.95 | $396K |
| Jan 06, 2026 | Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | SELL | 1.3K | $76.95 | $98K |
| Jan 06, 2026 | Christine Marie Utter | SVP, CHIEF ACCOUNTING OFFICER | SELL | 1.4K | $76.95 | $106K |
| Jan 06, 2026 | Pierre Gravier | CHIEF FINANCIAL OFFICER | SELL | 2.1K | $76.95 | $165K |
| Jan 06, 2026 | Lee Scott Golden | EVP & CHIEF MEDICAL OFFICER | SELL | 1.3K | $76.95 | $103K |
| Jan 06, 2026 | Mark Elliott Boulding | EXEC. VP AND CLO | SELL | 1.7K | $76.95 | $134K |
| Jan 06, 2026 | Eric Pauwels | CHIEF BUSINESS OFFICER | SELL | 1.8K | $76.95 | $138K |
| Jan 06, 2026 | Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | SELL | 54 | $76.95 | $4K |
| Jan 05, 2026 | Mark Elliott Boulding | EXEC. VP AND CLO | SELL | 1.0K | $76.10 | $79K |
| Jan 05, 2026 | Mark Elliott Boulding | EXEC. VP AND CLO | EXERCISE | 2.3K | $39.42 | $89K |
| Jan 05, 2026 | Mark Elliott Boulding | EXEC. VP AND CLO | SELL | 1.1K | $74.92 | $84K |
| Jan 05, 2026 | Mark Elliott Boulding | EXEC. VP AND CLO | SELL | 108 | $76.79 | $8K |
| Jan 05, 2026 | Emma Reeve | Director | EXERCISE | 734 | $46.54 | $34K |
| Jan 05, 2026 | Emma Reeve | Director | SELL | 734 | $76.00 | $56K |
| Jan 02, 2026 | Stephanie Okey | Director | GRANT | 4.0K | — | — |
| Jan 02, 2026 | Allan Steven Jacobson | Director | GRANT | 4.0K | — | — |
| Jan 02, 2026 | Christine Marie Utter | SVP, CHIEF ACCOUNTING OFFICER | GRANT | 13.2K | — | — |
| Jan 02, 2026 | David P Southwell | Director | GRANT | 4.0K | — | — |
| Jan 02, 2026 | Emma Reeve | Director | GRANT | 4.0K | — | — |
| Jan 02, 2026 | Eric Pauwels | CHIEF BUSINESS OFFICER | GRANT | 20.0K | — | — |
| Jan 02, 2026 | Glenn Phd Steele JR MD | Director | EXERCISE | 12.0K | $30.86 | $370K |
| Jan 02, 2026 | Glenn Phd Steele JR MD | Director | GRANT | 4.0K | — | — |
| Jan 02, 2026 | Glenn Phd Steele JR MD | Director | SELL | 12.0K | $76.35 | $916K |
| Jan 02, 2026 | Jerome B Zeldis | Director | GRANT | 4.0K | — | — |
| Jan 02, 2026 | Lee Scott Golden | EVP & CHIEF MEDICAL OFFICER | GRANT | 18.8K | — | — |
| Jan 02, 2026 | Mark Elliott Boulding | EXEC. VP AND CLO | GRANT | 17.0K | — | — |
| Jan 02, 2026 | Mary L. Smith | Director | GRANT | 4.0K | — | — |
| Jan 02, 2026 | Matthew B. Klein | CHIEF EXECUTIVE OFFICER | GRANT | 63.0K | — | — |
| Jan 02, 2026 | Michael Schmertzler | Director | GRANT | 8.0K | — | — |
| Jan 02, 2026 | Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | GRANT | 520 | — | — |
| Jan 02, 2026 | Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | GRANT | 17.5K | — | — |
| Jan 02, 2026 | Pierre Gravier | CHIEF FINANCIAL OFFICER | GRANT | 20.0K | — | — |
| Jan 02, 2026 | Alethia Young | Director | GRANT | 4.0K | — | — |
| Dec 30, 2025 | Matthew B. Klein | CHIEF EXECUTIVE OFFICER | SELL | 8.1K | $76.64 | $620K |
| Dec 18, 2025 | Eric Pauwels | CHIEF BUSINESS OFFICER | EXERCISE | 2.8K | $66.49 | $188K |
| Dec 18, 2025 | Eric Pauwels | CHIEF BUSINESS OFFICER | SELL | 120 | $75.02 | $9K |
| Dec 18, 2025 | Eric Pauwels | CHIEF BUSINESS OFFICER | EXERCISE | 120 | $66.49 | $8K |
| Dec 18, 2025 | Eric Pauwels | CHIEF BUSINESS OFFICER | EXERCISE | 251 | $18.01 | $5K |
| Dec 18, 2025 | Eric Pauwels | CHIEF BUSINESS OFFICER | SELL | 2.8K | $75.07 | $213K |
| Dec 18, 2025 | Eric Pauwels | CHIEF BUSINESS OFFICER | SELL | 251 | $75.00 | $19K |
| Dec 17, 2025 | Eric Pauwels | CHIEF BUSINESS OFFICER | EXERCISE | 35.4K | $66.49 | $2.4M |
| Dec 17, 2025 | Eric Pauwels | CHIEF BUSINESS OFFICER | EXERCISE | 3.7K | $18.01 | $66K |
| Dec 17, 2025 | Eric Pauwels | CHIEF BUSINESS OFFICER | SELL | 35.3K | $75.44 | $2.7M |
| Dec 17, 2025 | Eric Pauwels | CHIEF BUSINESS OFFICER | SELL | 3.6K | $75.31 | $270K |
| Dec 17, 2025 | Eric Pauwels | CHIEF BUSINESS OFFICER | EXERCISE | 1.2K | $66.49 | $83K |
| Dec 17, 2025 | Eric Pauwels | CHIEF BUSINESS OFFICER | SELL | 1.2K | $75.28 | $94K |
| Dec 17, 2025 | Eric Pauwels | CHIEF BUSINESS OFFICER | SELL | 100 | $76.00 | $8K |
| Dec 16, 2025 | Michael Schmertzler | Director | EXERCISE | 24.0K | $30.86 | $741K |
| Dec 03, 2025 | Emma Reeve | Director | EXERCISE | 733 | $46.54 | $34K |
| Dec 03, 2025 | Emma Reeve | Director | SELL | 733 | $78.62 | $58K |
| Dec 02, 2025 | Matthew B. Klein | CHIEF EXECUTIVE OFFICER | SELL | 3.4K | $79.07 | $271K |
| Dec 01, 2025 | Matthew B. Klein | CHIEF EXECUTIVE OFFICER | GRANT | 15.6K | — | — |